Study for Efficacy and Safety Assessment of the Drug RADAMIN®VIRO for COVID-19 Postexposure Prophylaxis
Status:
Completed
Trial end date:
2023-01-17
Target enrollment:
Participant gender:
Summary
This is Double-Blind, Placebo-Controlled Multicentre Clinical Phase III Study conducted in 10
medical facilities. The objective of the study is to evaluate efficacy and safety of the drug
Drug RADAMIN®VIRO, Lyophilisate for Preparation of Solution for Intramuscular and
Subcutaneous Administration for COVID-19 Postexposure Prophylaxis